|
|
Volumn 133, Issue 5, 1997, Pages 637-642
|
|
Recombinant cytokine treatment for scleroderma: Can the antifibrotic potential of interferon-γ be realized clinically?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COLLAGEN TYPE 1;
COLLAGEN TYPE 2;
COLLAGEN TYPE 3;
CYTOKINE;
GAMMA INTERFERON;
INTERLEUKIN 2;
RECOMBINANT GAMMA INTERFERON;
TRANSFORMING GROWTH FACTOR BETA;
AUTOIMMUNITY;
BLOOD VESSEL INJURY;
CHEMOTAXIS;
CLINICAL FEATURE;
CONNECTIVE TISSUE;
EDITORIAL;
FIBROBLAST;
FIBROGENESIS;
IMMUNOCOMPETENT CELL;
IMMUNOMODULATION;
LUNG FIBROSIS;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SKIN FIBROSIS;
SYSTEMIC SCLEROSIS;
|
|
EID: 0030977158
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.133.5.637 Document Type: Editorial |
|
Times cited : (22)
|
|
References (42)
|